NL300663I2 - - Google Patents

Download PDF

Info

Publication number
NL300663I2
NL300663I2 NL300663C NL300663C NL300663I2 NL 300663 I2 NL300663 I2 NL 300663I2 NL 300663 C NL300663 C NL 300663C NL 300663 C NL300663 C NL 300663C NL 300663 I2 NL300663 I2 NL 300663I2
Authority
NL
Netherlands
Prior art keywords
recombinant
multimodal
potency
purifying
purification
Prior art date
Application number
NL300663C
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NL300663I2 publication Critical patent/NL300663I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL300663C 2007-07-11 2014-04-15 NL300663I2 (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07112287 2007-07-11
EP08786090A EP2167526B1 (en) 2007-07-11 2008-07-11 Purification of factor viii using a mixed-mode or multimodal resin
PCT/EP2008/059094 WO2009007451A1 (en) 2007-07-11 2008-07-11 Purification of factor viii using a mixed-mode or multimodal resin

Publications (1)

Publication Number Publication Date
NL300663I2 true NL300663I2 (nl) 2016-09-22

Family

ID=38472947

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300663C NL300663I2 (nl) 2007-07-11 2014-04-15

Country Status (15)

Country Link
US (1) US8399620B2 (nl)
EP (1) EP2167526B1 (nl)
JP (1) JP5323072B2 (nl)
KR (1) KR101293504B1 (nl)
CN (1) CN101730707B (nl)
AT (1) ATE503763T1 (nl)
AU (1) AU2008274195B2 (nl)
BR (1) BRPI0814220B8 (nl)
CA (1) CA2692814A1 (nl)
DE (1) DE602008005885D1 (nl)
ES (1) ES2364118T3 (nl)
NL (1) NL300663I2 (nl)
PL (1) PL2167526T3 (nl)
RU (1) RU2493163C2 (nl)
WO (1) WO2009007451A1 (nl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101804136B1 (ko) * 2008-06-24 2017-12-04 옥타파마 아게 응고 인자 ｖｉｉｉ을 정제하는 방법
RU2011110459A (ru) 2008-08-21 2012-09-27 Октафарма АГ (CH) Рекомбинантно полученный человеческий фактор viii и ix
US8945895B2 (en) 2009-07-31 2015-02-03 Baxter International Inc. Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof
US8277649B2 (en) 2009-12-14 2012-10-02 General Electric Company Membranes and associated methods for purification of antibodies
NO2538968T3 (nl) 2010-02-24 2018-03-31
DK3133157T3 (da) 2010-03-30 2019-08-12 Octapharma Ag Fremgangsmåde til oprensning af vitamin k-afhængige proteiner
US9453045B2 (en) 2010-03-30 2016-09-27 Octapharma Ag Process for the purification of a growth factor protein
EP2635600B1 (en) 2010-11-05 2017-06-21 F. Hoffmann-La Roche AG Optimized method for antibody capturing by mixed mode chromatography
WO2012082933A1 (en) 2010-12-15 2012-06-21 Baxter International, Inc. Eluate collection using conductivity gradient
WO2013075740A1 (en) 2011-11-23 2013-05-30 Sanofi Antibody purification method
CN111172135A (zh) 2012-10-24 2020-05-19 建新公司 使用mes和mops作为流动相改性剂从多峰树脂洗脱生物分子
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
CN103396494B (zh) * 2013-04-27 2015-04-01 江苏省疾病预防控制中心 一种凝血因子ix的单克隆抗体
EP2994485B1 (en) * 2013-05-06 2018-01-10 Sanofi Continuous multistep process for purifying antibodies
WO2015200645A1 (en) * 2014-06-25 2015-12-30 Jhl Biotech, Inc. Methods and reagents for purification of proteins
MX2017000862A (es) 2014-08-04 2017-05-01 Csl Ltd Formulacion de factor viii.
US11155601B2 (en) 2015-03-06 2021-10-26 CSL Behring Lengnau AG Modified von Willebrand factor having improved half-life
GB201506113D0 (en) 2015-04-10 2015-05-27 Ge Healthcare Bio Sciences Ab Method for chromatography
GB201506117D0 (en) 2015-04-10 2015-05-27 Ge Healthcare Bio Sciences Ab Method for chromatography
EP3205665A1 (en) * 2016-02-11 2017-08-16 Octapharma AG Method of separating factor viii from blood products
GB201617240D0 (en) * 2016-10-11 2016-11-23 Profactor Pharma Ltd Purification process
KR20220029733A (ko) 2019-07-04 2022-03-08 체에스엘 베링 렝나우 아게 응고 인자 viii의 시험관내 안정성을 증가시키기 위한 절단된 폰 빌레브란트 인자 (vwf)
JP2023500953A (ja) 2019-11-11 2023-01-11 ツェー・エス・エル・ベーリング・レングナウ・アクチエンゲゼルシャフト 第ｖｉｉｉ因子に対する寛容を誘導するためのポリペプチド

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302006D0 (sv) * 1992-10-02 1993-06-11 Kabi Pharmacia Ab Protein formulation
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation
SE503424C2 (sv) * 1994-11-14 1996-06-10 Pharmacia Ab Process för rening av rekombinant koagulationsfaktor VIII
IL157309A0 (en) 2003-08-07 2004-02-19 Applied Research Systems Method for the purification of a non-immunoglobulin protein
ES2395544T3 (es) * 2004-12-23 2013-02-13 Novo Nordisk Health Care Ag Reducción del contenido de contaminantes proteínicos en composiciones que comprenden una proteína dependiente de la vitamina K de interés
EP1707634A1 (en) * 2005-03-29 2006-10-04 Octapharma AG Method for isolation of recombinantly produced proteins
KR101804136B1 (ko) 2008-06-24 2017-12-04 옥타파마 아게 응고 인자 ｖｉｉｉ을 정제하는 방법

Also Published As

Publication number Publication date
US20100204452A1 (en) 2010-08-12
CN101730707B (zh) 2014-12-17
RU2493163C2 (ru) 2013-09-20
CN101730707A (zh) 2010-06-09
US8399620B2 (en) 2013-03-19
AU2008274195A1 (en) 2009-01-15
KR20100051620A (ko) 2010-05-17
BRPI0814220B1 (pt) 2019-09-17
PL2167526T3 (pl) 2011-09-30
EP2167526A1 (en) 2010-03-31
ES2364118T3 (es) 2011-08-25
WO2009007451A1 (en) 2009-01-15
BRPI0814220B8 (pt) 2021-05-25
CA2692814A1 (en) 2009-01-15
AU2008274195B2 (en) 2013-09-05
BRPI0814220A2 (pt) 2015-01-06
DE602008005885D1 (de) 2011-05-12
EP2167526B1 (en) 2011-03-30
JP5323072B2 (ja) 2013-10-23
ES2364118T9 (es) 2014-05-19
JP2010533150A (ja) 2010-10-21
ATE503763T1 (de) 2011-04-15
KR101293504B1 (ko) 2013-08-07
RU2010103528A (ru) 2011-08-20

Similar Documents

Publication Publication Date Title
NL300663I2 (nl)
MX2018014395A (es) Aislamiento y purificacion de anticuerpos usando la cromatografia de afinidad de proteina a.
AU2017263237A1 (en) GDF15 fusion proteins and uses thereof
MX341136B (es) Aislamiento y purificacion de los anticuerpos anti-il-13 al usar la cromatografia de afinidad con proteina a.
WO2009147248A3 (en) Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
IL226717A (en) Isolated nucleic acids encoded by anti-beta human antibodies 7
MX2010005783A (es) Secuencias de aminoacidos dirigidas contra citoquinas heterodimericas y/o sus receptores y polipeptidos que comprenden las mismas.
IL172729A0 (en) Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins
MX2010000196A (es) Prevencion de reduccion de enlaces de disulfuro durante la produccion recombinante de polipeptidos.
MX2020003798A (es) Metodos para la purificacion de arilsulfatasa a.
MX2008012748A (es) Un proceso para la concentracion de un polipeptido.
WO2009095489A3 (en) Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
MX2010002769A (es) Preparacion recombinante de fracciones de bromelaina seleccionadas.
TW200715985A (en) Systems and methods for separating proteins from connective tissue
MX2021011726A (es) Escindasas modificadas, usos de las mismas y kits relacionados.
EP3889164A4 (en) DEPROTECTION METHODS AND RESIN REMOVAL METHODS IN THE SOLID PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND AND METHODS FOR PRODUCTION OF A PEPTIDE COMPOUND
NZ781143A (en) Anti-vegf protein compositions and methods for producing the same
WO2004002418A3 (en) Compositions and methods comprising protein activated receptor antagonists
WO2010142551A8 (en) Amino acid sequences directed against receptors to cytokines belonging to the il-17 family
WO2007063129A3 (en) Insolation of peptides , polypeptides and proteins
DE502004007067D1 (de) Verfahren zur herstellung zyklischer moleküle
EP1984013A4 (en) CST II MODIFICATIONS FOR INCREASED PROTEIN EXPRESSION
ATE451457T1 (de) Verfahren zur dipeptidherstellung
IL284402A (en) A process for the production, isolation and purification of modified recombinant proteins
WO2010040736A3 (en) Amino acid sequences directed against il18 and/or the il-18 receptor and polypeptides comprising the same for the treatment of diseases and/or disorders associated with il-18 mediated signaling